Biosphere

Biosphere

Provides industrial bioreactors for sustainable bioproducts

Overview

Biosphere develops and integrates bioreactor technology to power industrial biomanufacturing for sustainable production of global commodities like food, fuel, and materials. It deploys bioreactor systems inside large-scale facilities, providing hardware, integration, and ongoing services to tailor and optimize bioproduct production. The company differentiates itself by pairing advanced bioreactors with platform-scale integration and offering licensing and deployment options for industrial adoption in the global commodities market. Its goal is to make large-scale bioproduct production financially viable and environmentally sustainable, accelerating the shift from monocropping, factory farming, and petroleum refining to bio-based production worldwide.

About Biosphere

Simplify's Rating
Why Biosphere is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Industrial & Manufacturing

Energy

Biotechnology

Company Size

11-50

Company Stage

Seed

Total Funding

$8.8M

Headquarters

Oakland, California

Founded

2022

Get referred to Biosphere

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • May 2026 Army OTA reached $9 million, extending Biosphere's funded runway and credibility.
  • June 2026 acquisition expands addressable markets into defense, industrial manufacturing, and advanced materials.
  • NovoNutrients' validated pilot systems strengthen Biosphere's path toward 20,000-liter demonstration scale.

What critics are saying

  • Hydrogen supply and gas-liquid mass transfer still constrain scale-up economics through 2027.
  • Continuous food production for 18 warfighters faces validation risk before the 42-month Army program ends.
  • If pilot performance disappoints, Biosphere remains a hardware concept without recurring commercial revenue.

What makes Biosphere unique

  • UV sterilization replaces steam-in-place, cutting bioreactor capital and maintenance complexity.
  • June 2026 NovoNutrients acquisition adds gas fermentation, loop-reactor, and process-development expertise.
  • Army and DoW contracts validate modular systems for contested logistics and austere environments.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$8.8M

Above

Industry Average

Funded Over

1 Rounds

Notable Investors:
Seed funding is usually the first official round after pre-seed, when a startup has a prototype or concept. It’s typically used to develop the product, test the market, and start building the team. Investors here are often angel investors or early-stage venture capitalists.
Seed Funding Comparison
Above Average

Industry standards

$3.3M
$2M
Netflix
$2.3M
Instacart
$3M
Robinhood
$8.8M
Biosphere

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Paid Vacation

Paid Sick Leave

Paid Holidays

Parental Leave

Company Equity

Gym Membership

Growth & Insights and Company News

Headcount

6 month growth

-4%

1 year growth

-4%

2 year growth

-4%
The Manila Times
Jun 30th, 2026
Biosphere expands biomanufacturing platform with NovoNutrients acquisition.

Biosphere expands biomanufacturing platform with NovoNutrients acquisition. By GlobeNewswire June 30, 2026 Acquisition strengthens Biosphere's advanced bioreactor platform and accelerates development of bioproducts across defense, industrial and commercial markets OAKLAND, Calif., June 30, 2026 (GLOBE NEWSWIRE) - Biosphere, a U.S.-based leader in biomanufacturing technology, today announced the acquisition of NovoNutrients, a pioneer in gas fermentation, reactor design, and industrial bioprocess development. Biosphere's UV sterilization platform replaces conventional steam-based sterilization, expanding the design space for high-performance bioreactors. The NovoNutrients acquisition accelerates the application of their platform to intensified reactor designs, giving Biosphere a strong foundation in gas fermentation and high-intensity aerobic fermentation for a wide range of defense, industrial, and commercial applications. "At Biosphere, we see immense potential in developing next-generation reactor designs for intensified bioprocessing," said Brian Heligman, PhD, Co-Founder and CEO of Biosphere. "The NovoNutrients platform plays perfectly into our active Department of War contracts and gives us a strong foundation with an established FEL3 design of a loop reactor pilot plant. We are excited to further develop this technology and leverage its high mass-transfer performance for bioprocessing of both next-generation gas and carbohydrate feedstocks." NovoNutrients' proprietary loop reactor technology was designed to address one of the most significant challenges in industrial biomanufacturing: efficiently transferring gaseous feedstocks into biological systems at scale. The reactor architecture improves gas-liquid mass transfer and fluid circulation while reducing the energy and maintenance requirements associated with traditional mechanically agitated bioreactors. The technology has been validated at multiple scales, from laboratory development through containerized pilot systems, and has informed the design and modeling of commercial-scale reactors. The acquisition represents a significant step in Biosphere's broader mission to build infrastructure for the emerging bioindustrial economy, expanding its technical and operational capabilities at a time when governments and industry are prioritizing domestic manufacturing resilience, supply chain security, and bioindustrial capacity. It also builds on Biosphere's recent momentum, including a $9 million agreement with the U.S. Army Combat Capabilities Development Command Soldier Center (DEVCOM SC) to develop modular biomanufacturing systems capable of producing nutrition in austere environments, while strengthening the company's ability to pursue new opportunities across defense supply chain, industrial manufacturing, specialty chemicals, and advanced materials. About Biosphere Biosphere is developing next-generation biomanufacturing systems designed for scale, reliability, and cost efficiency. By replacing traditional steam-based infrastructure with proprietary UV sterilization, the company enables simpler, modular production that can be deployed anywhere. Biosphere serves as a manufacturing partner for the bioeconomy, supporting the production of food, fuels, chemicals, and materials through efficient, rapidly deployable systems. Its platform is designed to unlock new categories of bioproduction and strengthen domestic supply chains. For more information, visit www.biosphere.io About NovoNutrients Founded in 2017 and based in Sunnyvale, California, NovoNutrients developed a gas fermentation platform for converting industrial CO2 emissions and hydrogen into single cell protein for food and feed applications. The company raised more than $22 million across multiple rounds, including an $18 million Series A led by Woodside Energy and CM Venture Capital, with earlier backing from SOSV/IndieBio and other investors. The company's intellectual property, microbial strains, and accumulated process expertise are now part of Biosphere. Media Contact Emily Richard Communications Strategy Group (CSG)

GlobeNewswire
Jun 30th, 2026
Biosphere acquires NovoNutrients to expand gas fermentation capabilities

Biosphere, a US-based biomanufacturing technology company, has acquired NovoNutrients, a pioneer in gas fermentation and industrial bioprocess development. The deal strengthens Biosphere's platform, which uses UV sterilisation to replace conventional steam-based methods in bioreactor design. NovoNutrients' proprietary loop reactor technology improves gas-liquid mass transfer whilst reducing energy and maintenance costs compared to traditional bioreactors. The technology has been validated from laboratory to pilot scale. Founded in 2017, NovoNutrients raised over $22 million, including an $18 million Series A led by Woodside Energy and CM Venture Capital. The acquisition follows Biosphere's recent $9 million agreement with the US Army to develop modular biomanufacturing systems, and supports the company's expansion into defence, industrial manufacturing and advanced materials sectors.

AgFunder
May 5th, 2026
Pentagon awards Biosphere $9M to develop portable "protein from air" bioreactors

Biosphere, a California-based startup developing UV-sterilised bioreactors, has secured a $9 million grant from the US Department of Defense over 3.5 years to develop portable bioreactors producing protein via gas fermentation. Founded in 2022, Biosphere's core technology uses UV light instead of costly steam-in-place systems to sterilise bioreactors, reducing capital and maintenance costs whilst enabling smaller, more productive designs. The company has validated the technology at benchtop scale and is developing a 20,000-litre demonstration facility. The DoD project will produce a prototype with continuous operation capabilities, UV sterilisation protocols, water and media recycling systems, and downstream processing. Biosphere recently acquired intellectual property from a distressed gas fermentation company making "protein from air" to deploy in the project, according to co-founder Brian Heligman.

AdvanceH2
May 5th, 2026
Pentagon funds innovative bioreactor project for sustainable protein production from air.

Pentagon funds innovative bioreactor project for sustainable protein production from air. Key points. * Biosphere secures $9 million from DoD to develop portable bioreactors for protein production. * The project will utilize UV sterilization to reduce biomanufacturing costs and enhance efficiency. * Gas fermentation technology will be explored for producing food and feed from unconventional feedstocks. * Challenges remain in scaling gas fermentation, particularly in sourcing sustainable hydrogen. Biosphere, a California-based startup, has recently received a significant financial boost from the U.S. Department of Defense (DoD), securing a grant of $9 million over a period of 3.5 years to develop innovative portable bioreactors designed to produce protein through gas fermentation. This initiative aligns with the DoD's strategic focus on biomanufacturing, aimed at creating distributed production systems capable of operating in environments where traditional supply channels are compromised. The project will ultimately produce a prototype bioreactor that operates continuously, utilizing UV sterilization methods, which are intended to streamline operations and enhance the efficiency of biomanufacturing processes. The innovative approach by Biosphere focuses on employing ultraviolet light for sterilization, which eliminates the need for traditional, expensive steam-in-place systems typically used in bioreactor operations. This is expected to not only reduce capital and operational expenses but also allow for the development of smaller, more productive bioreactors that are less constrained by existing sterilization protocols. Following validations at various scales, Biosphere is moving towards a 20,000-liter demonstration facility, showcasing their commitment to advancing biomanufacturing technology. Gas fermentation, while primarily known for producing fuel and chemicals, is increasingly being recognized for its potential in food and feed production. The DoD project will delve into innovative bioreactor designs that facilitate gas fermentation processes, particularly focusing on using gases as feedstocks instead of traditional sugars. This could lead to lower input costs and longer fermentation campaigns due to reduced contamination risks. However, challenges persist, especially in handling gases like hydrogen, which has limited solubility in liquid, complicating the gas-liquid mixing process critical for effective fermentation. Biosphere aims to tackle these challenges by developing bioreactor systems designed specifically for gas fermentation applications, emphasizing low-cost and efficient scaling opportunities. The strategic involvement with the DoD is seen as critical to exploring more avant-garde designs that might otherwise be overlooked in the private sector, where more conservative approaches dominate. Moving forward, Biosphere sees potential in collaborating with other gas fermentation companies, perhaps through technology licensing or joint ventures, to further innovate in this promising yet complex field of biomanufacturing. Overall, the funding from the Pentagon not only exemplifies a commitment to advancing biotechnological solutions but also highlights the growing interest in sustainable protein production methods that harness atmospheric gases, including hydrogen, to meet future food production needs. May 5, 2026 at 07:00 PM California, United States

The Manila Times
May 5th, 2026
Biosphere awarded $9 million U.S. Army contract to develop on-demand nutrition production system for warfighters.

Biosphere awarded $9 million U.S. Army contract to develop on-demand nutrition production system for warfighters. By GlobeNewswire May 5, 2026 OAKLAND, Calif., May 05, 2026 (GLOBE NEWSWIRE) - Biosphere, a U.S.-based pioneer in biomanufacturing technology, today announced the award of an Other Transaction Authority (OTA) agreement with a total potential value of up to $9 million. The agreement was awarded by the Office of the Undersecretary of War (OSW) Manufacturing Science and Technology Program (MSTP) via the U.S. Army Combat Capabilities Development Command Soldier Center (DEVCOM SC). Consisting of a baseline effort and three subsequent options, the project will fund the development of a portable biomanufacturing system capable of producing protein rations from air, water, and energy. This initiative aligns with the Department of War's (DoW) strategic focus on biomanufacturing and contested logistics-priorities supported by a planned investment of over $300 million in bioindustrial manufacturing for fiscal year 2026. This 42-month contract funds the design, development, and demonstration of a field-deployable system that synthesizes ready-to-eat meals for warfighters operating in contested, remote, and logistically constrained environments. The technology aims to reduce reliance on complex supply chains by enabling on-site production of 2,800 calories per person per day for up to 18 warfighters, with plans to scale the system to support 250 personnel. "This contract represents a significant milestone in our mission to advance rapidly deployable biomanufacturing systems," said Brian Heligman, PhD, Co-Founder and CEO of Biosphere. "By leveraging our proprietary UV-sterilized bioreactor technology, we're developing a system that can produce nutritious, shelf-stable food anywhere, eliminating traditional supply chain constraints and enhancing operational readiness for our military." The project will progress through multiple phases, beginning with process selection and design, advancing through pilot-scale demonstrations, and culminating in a full-scale prototype capable of continuous operation. Key innovations include UV sterilization protocols for contamination-free production, water and media recycling systems, and downstream processing to create lightweight, nutrient-dense, ready-to-eat foods. "This effort reflects the military's focus on advancing resilient, forward-deployed capabilities that reduce logistical burden and enhance operational flexibility," said Nicole Favreau Farhadi, Technical Lead, U.S. Army DEVCOM Soldier Center. "Technologies that enable on-site production of critical resources, beginning with nutrition, represent an important step toward more adaptive and distributed sustainment in future operating environments." Building on this capability, Arye Lipman, Co-Founder and COO of Biosphere, added: "This program will validate our platform's ability to deliver autonomous, point-of-need biomanufacturing. While nutrition is the initial application, the platform can produce fuels, chemicals, and advanced materials, with potential to expand distributed manufacturing in remote and resource-constrained environments." The contract was awarded through the Army's ACC-APG Natick Division, Combat Feeding Division which leads research and development efforts in Soldier nutrition and combat feeding systems. Work will be performed at Biosphere's facilities in California, with final product samples delivered to the Combat Feeding Division for evaluation. About Biosphere Biosphere is developing next-generation biomanufacturing systems designed for scale, reliability, and cost efficiency. By replacing traditional steam-based infrastructure with proprietary UV sterilization, the company enables simpler, modular production that can be deployed anywhere. Biosphere serves as a manufacturing partner for the bioeconomy, supporting the production of food, fuels, chemicals, and materials through efficient, rapidly deployable systems. Its platform is designed to unlock new categories of bioproduction and strengthen domestic supply chains. For more information, visit www.biosphere.io About DEVCOM Soldier Center The DEVCOM Soldier Center is committed to discovering, developing, and advancing science and technology solutions that ensure America's warfighters are optimized, protected, and lethal. DEVCOM Soldier Center supports all of the Army's Modernization efforts, with the Soldier Lethality and Synthetic Training Environment Cross Functional Teams being the DEVCOM Soldier Center's chief areas of focus. The center's science and engineering expertise are combined with collaborations with industry, DOD, and academia to advance Soldier and squad performance. The center supports the Army as it transforms from being adaptive to driving innovation to support a Multi-Domain Operations Capable Force of 2028 and a MDO Ready Force of 2035. DEVCOM Soldier Center is constantly working to strengthen Soldiers' performance to increase readiness and support for warfighters who are organized, trained, and equipped for prompt and sustainable ground combat. Media Contact: Emily Richard Communications Strategy Group (CSG) [email protected]

Recently Posted Jobs

Sign up to get curated job recommendations

Biosphere is Hiring for 1 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →